Dendreon (DNDN) Reports Q3 Loss of $0.40, Misses by 19c
More News related to DNDN
- Dendreon (DNDN) January volatility at 58, May at 99 into meeting
- Dendreon Corp. (DNDN) Receives U.S. FDA Complete Response for PROVENGE CRPC Treatment
- Dendreon Receives FDA Acknowledgement of Complete Response
- Leerink Says Takeaway From Dendreon's (DNDN) Q3 Report is the Busy Preparations for Provenge
- Dendreon (DNDN) Reports Q3 Loss of $0.40, Misses by 19c
More News related to Earnings
- J. Crew (JCG) "Simply" Beats Q3 Earnings Views
- China Finance Online (JRJC) Tops Q3 EPS by 1c; Guides In-line for Q4 Revs
- Giant Interactive (GA) Tops Q3 Earnings Views
- Halliburton (HAL) Announced Major Reduction in Activity from Customer in Mexico; Sees Impact to Q4 Earnings
- Coldwater Creek (CWTR) Reports Mixed Q3 Results
Dendreon Corp. (Nasdaq: DNDN) reports Q3 loss of $0.40, 19 cents lower than the analyst estimate of ($0.21). Revenue for the quarter was $25K, which compares to the estimate of $580K.
Related Categories
EarningsStocks Mentioned
-0.34Comments
Manipulation
When is this stock not being maniiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
DENDRON
THIS WAS REPORTED ON 11/09. WHY THE SENSATIONAL HEADLINES TODAY? IS SOMEONE TRYING TO MANIPULATE THE PRICE OF THE STOCK?
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
Manipulation
STEPHEN KRUPINSKI on Nov 11, 2009 07:44 PMWhen is this stock not being maniiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii